Kvartalet oktober – december 2022 Orderingången uppgick till 216,6 (132,9) MSEK, en ökning med 63 procent (49 procent i konstanta valutor). Orderstocken uppgick till 616,0 (425,3) MSEK. Intäkterna uppgick till…
Read More
Invitation to join the presentation of C-RAD’s fourth quarter 2022. Date: Thursday January 26, 2023 / kl. 11:00 CET Venue: Online Presentation Topic: C-RAD Year-end Report 2022 Procedure: Please register…
Invitation to join the presentation of C-RAD’s fourth quarter 2022. Date: Thursday January 26, 2023 / kl. 11:00 CET Venue: Online Presentation Topic: C-RAD Year-end Report 2022 Procedure: Please register…
C-RAD appoints Christoffer Herou as CFO, starting end of Q2, 2023 Christoffer Herou, 41 years old, holds a Master of Science in Business Administration from Lund University. He most recently…
C-RAD utser Christoffer Herou till CFO, med start slutet av Q2, 2023 Christoffer Herou, 41 år, har en Master of Science i Business Administration från Lunds Universitet. Han kommer senast…
C-RAD AB (Publ) has appointed Cecilia de Leeuw as new CEO, effective today. She will lead C-RAD in providing essential radiotherapy treatment solutions that contribute to improving cancer patient’s treatment…
C-RAD announced the decision for positioning technology in a country wide tender in Italy in October. The C-RAD distributor – Tecnosan SRL – won the SGRT (Surface Guided Radiation Therapy)…
C-RAD tillkännagav beslutet om positioneringsteknik i en landsomfattande upphandling i Italien i oktober. Upphandlingen för SGRT (Surface Guided Radiation Therapy) är vunnen av C-RAD-distributören – Tecnosan SRL och inkluderar Catalyst-…
C-RAD proudly announces their research partnership with PSG Hospitals, Coimbatore, India. The collaboration aims to create awareness of the technology, and to include SGRT in course curriculum. PSG Hospitals is…
C-RAD tillkännager idag ett partnerskapsavtal med Renova Oncology Group baserade i Hyderabad, Indien. Avtalet inkluderar en order på flera Catalyst+ HD- och Sentinel 4DCT-system och ett flerårigt serviceavtal. Renova Oncology…